• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    US Melanoma Market Size

    ID: MRFR/Pharma/2164-HCR
    50 Pages
    Kinjoll Dey
    September 2025

    US Melanoma Market Share And Trends Analysis By Type (Superficial Spreading, Nodular, Lentigo Maglina, Acral Lentigious And Others); Gender (Male And Female); Treatment (Immunotherapy, Biologic Therapy, Radiation Therapy, Chemotherapy, Surgery And Others); Diagnosis (Abcde, Ugly Duckling, Biopsy And Others), End Users (Hospitals, Pharmaceutical Companies, Research Centers, Clinics, Laboratories...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Melanoma Market Research Report- Forecast To 2032 Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Us Melanoma Size

    US Melanoma Market Growth Projections and Opportunities

    Sun-drenched areas have higher melanoma cases. This implies locals are more prone to acquire it. Better treatments, prevention, and early detection are needed for melanoma. Melanoma is more common in certain skin types and populations. People live longer and spend more time in the sun, making it more frequent. Lighter skinned people are more prone to have it. Melanoma medical services are affected by age and group migration. Melanoma awareness efforts have a huge impact on the market. People adjust their behavior when taught about the hazards of sun exposure, early detection, and cancer prevention. This alters screening and treatment needs. The melanoma market requires genetic testing and dermoscopy to discover malignancy. Better, more accurate testing techniques help detect issues early. Treatment and assistance may start sooner. New approaches for quicker and simpler cancer detection are needed. Oncology research and development programs enhance melanoma therapies. Targeted medications, immunotherapies, and combination therapy are improving and personalizing melanoma treatment, transforming the market. How accessible and effective medical treatment is may affect the cancer market. Well-established hospitals and cancer centers impact the market. These facilities manage early assessment, treatment, and long-term care well. Melanoma drug prices impact patient choices and market movement. Advanced and expensive care is available to those with insurance that covers many tests and treatments. Government health organizations must approve melanoma medications before they may be developed, marketed, or used. Follow established regulations to ensure medication and procedure safety and efficacy. This affects market acceptance. Government, private organizations, and pharma firms support melanoma research to improve treatment. Funding melanoma research to develop targeted medicines and enhance treatment results drives market growth. More individuals want to know how genetics and signals might predict melanoma and help them pick a therapy. Biomarkers and genetic testing enable tailored medicine, which transforms the market by providing more targeted treatment. Global health issues like pandemics might impact the melanoma industry. Melanoma detection and management may alter as healthcare objectives, resources, and patients' activities change while unwell. Market dynamics shift when patient support and political organizations grow. Melanoma patients may get aid via these organizations. They also influence health policy and educate about the condition.

    Market Size Graph

    Market Summary

    The US Melanoma market is projected to grow from 7.5 USD Billion in 2024 to 15 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    US Melanoma Key Trends and Highlights

    • The US Melanoma market is valued at 7.5 USD Billion in 2024.
    • By 2035, the market is expected to reach 15 USD Billion, indicating substantial growth.
    • The compound annual growth rate (CAGR) for the period from 2025 to 2035 is estimated at 6.5%.
    • Growing adoption of advanced treatment options due to increasing awareness of melanoma is a major market driver.

    Market Size & Forecast

    2024 Market Size 7.5 (USD Billion)
    2035 Market Size 15 (USD Billion)
    CAGR (2025 - 2035) 6.5%
    Largest Regional Market Share in 2024 -)

    Major Players

    Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Tesla Inc (US), Meta Platforms Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

    Market Trends

    The increasing incidence of melanoma in the United States underscores the urgent need for enhanced public awareness and innovative treatment strategies to combat this aggressive skin cancer.

    Centers for Disease Control and Prevention (CDC)

    US Melanoma Market Market Drivers

    Market Growth Projections

    The Global US Melanoma Market Industry is projected to experience substantial growth, with estimates indicating a market value of 7.5 USD Billion in 2024 and a potential increase to 15 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate (CAGR) of 6.5% from 2025 to 2035. Such projections highlight the increasing demand for melanoma treatments and the ongoing advancements in medical technology. The market's expansion is likely driven by factors such as rising incidence rates, improved treatment options, and heightened public awareness, positioning the industry for a promising future.

    Increased Public Awareness

    Public awareness campaigns regarding skin cancer and melanoma are playing a crucial role in the Global US Melanoma Market Industry. Initiatives by health organizations aim to educate the public about the risks of UV exposure and the importance of regular skin checks. This heightened awareness leads to earlier detection and treatment of melanoma, which is vital for improving survival rates. As more individuals become informed about melanoma, the demand for screening and treatment services is likely to rise. This trend is expected to contribute to the market's growth trajectory, aligning with the projected CAGR of 6.5% from 2025 to 2035.

    Rising Incidence of Melanoma

    The Global US Melanoma Market Industry is experiencing growth due to the increasing incidence of melanoma cases. Data indicates that melanoma rates have been rising steadily, with approximately 100,000 new cases expected in 2024 alone. This surge in cases necessitates enhanced treatment options and healthcare resources, driving market expansion. As awareness of skin cancer increases, more individuals seek early diagnosis and treatment, further contributing to the industry's growth. The projected market value of 7.5 USD Billion in 2024 reflects this trend, as healthcare providers and pharmaceutical companies respond to the growing demand for effective melanoma therapies.

    Advancements in Treatment Options

    Innovations in treatment modalities are significantly impacting the Global US Melanoma Market Industry. The introduction of targeted therapies and immunotherapies has revolutionized melanoma treatment, offering patients more effective options. For instance, drugs like pembrolizumab and nivolumab have shown promising results in clinical trials, leading to improved survival rates. As these therapies gain approval and become more widely available, the market is expected to expand. The anticipated growth to 15 USD Billion by 2035 underscores the potential of these advancements to reshape treatment paradigms and enhance patient outcomes in melanoma care.

    Regulatory Support for Drug Approvals

    Regulatory bodies are increasingly supporting the development and approval of new melanoma treatments, which is beneficial for the Global US Melanoma Market Industry. The expedited approval processes for innovative therapies, particularly in oncology, facilitate quicker access to life-saving medications for patients. This regulatory environment encourages pharmaceutical companies to invest in research and development for melanoma treatments. As a result, the market is poised for growth, with the potential for new therapies to enter the market and meet the needs of patients. This supportive framework is likely to enhance the industry's overall landscape.

    Growing Investment in Research and Development

    Investment in research and development is a key driver for the Global US Melanoma Market Industry. Pharmaceutical companies and research institutions are increasingly allocating resources to discover novel treatments and improve existing therapies. This focus on R&D is crucial for addressing the unmet needs in melanoma care, as researchers explore new drug combinations and treatment strategies. The anticipated growth of the market to 15 USD Billion by 2035 reflects the potential outcomes of these investments. As breakthroughs in melanoma research emerge, they may lead to more effective therapies and improved patient outcomes.

    Market Segment Insights

    Regional Insights

    Key Companies in the US Melanoma Market market include

    Industry Developments

    Future Outlook

    US Melanoma Market Future Outlook

    The US Melanoma Market is projected to grow at a 6.5% CAGR from 2024 to 2035, driven by advancements in immunotherapy, increased awareness, and early detection technologies.

    New opportunities lie in:

    • Invest in novel immunotherapy treatments to enhance patient outcomes.
    • Develop AI-driven diagnostic tools for early melanoma detection.
    • Expand telemedicine services for remote patient monitoring and consultations.

    By 2035, the US Melanoma Market is expected to exhibit robust growth, reflecting advancements in treatment and patient care.

    Market Segmentation

    Report Scope

     

    Attribute/Metric Details
    Market Size 2032   USD 5.73 Billion
    Compound Annual Growth Rate (CAGR)   10.8% (2022-2032)
      Base Year 2022
      Forecast Period   2023-2032
      Historical Data 2019 - 2022
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Type, Gender, Treatment, Diagnosis, End Users
      Geographies Covered   South Africa, Egypt, Nigeria, Morocco and Algeria
      Key Vendors Amgen, Inc., Bristol-Myers Squibb, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., Genentech Inc. Janssen Biotech, Inc., and Novartis International AG. Pfizer, Vical and Ziopharm.
      Key Market Drivers   Technological advancement in the field of treatment and diagnosis of melanoma in the US also drives this market.

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    1. Increasing awareness regarding skin cancer
      1. Increased emphasis on early detection of cancer
        1. Increasing inclination towards preventive care
      2. Restrains
        1. Risk Associated with blood transfusion
      3. Porter’s Five Forces Model
        1. Bargaining power of suppliers
        2. Bargaining Power of Buyers
        3. Threat of New Entrants
        4. Threat of Substitutes
        5. Intensity of Rivalry
      4. Supply Chain Analysis
      5. Superficial melanoma
      6. Nodular Melanoma
      7. Lentigo Maglina Melanoma
      8. Acral Lentigious
      9. Others
      10. Male
      11. Female
      12. Immunotherapy
      13. Biological therapy
      14. Radiation
      15. Chemotherapy
      16. Surgery
      17. Others
      18. ABCDE
      19. Ugly Duckling
      20. Biopsy
      21. Others
      22. Hospitals
      23. Pharmaceutical Companies
      24. Research centres
      25. Clinics
      26. Laboratories
      27. Pricing
    2. of drugs for melanoma
      1. Production Capacity of Major Players
      2. Amgen Inc.
        1. Overview
        2. Product/Business Segment Overview
        3. Financial Updates
        4. Key Developments
      3. Eristol-Mayers Squibb
        1. Overview
        2. Product/Business Segment Overview
        3. Financial Updates
        4. Key Developments
      4. Eisai Co Ltd.
        1. Overview
        2. Product/Business Segment Overview
        3. Financial Updates
      5. F Hoffmann-La Roche Ltd
        1. Overview
        2. Product/Business Segment Overview
        3. Financial Updates
      6. Genetech Inc.
        1. Overview
        2. Product/Business Segment Overview
        3. Financial Updates
        4. Key Developments
      7. Janssen Biotech
        1. Overview
        2. Product/Business Segment Overview
        3. Financial Updates
        4. Key Developments
      8. Pfizer
        1. Company Overview
        2. Product/Business Segment Overview
        3. Financial Updates
        4. Key Development
      9. Novartis
        1. Overview
        2. Product/Business Segment Overview
        3. Financial Overview
      10. Vical
        1. Overview
        2. Product/Business Segment Overview
        3. Financial Overview
      11. Ziopharm
        1. Overview
        2. Product/Business Segment Overview
        3. Financial Overview

    US Melanoma Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study

    Smartphone Motherboard Parts Manufacturing Research